SWM
GNOM icon

SHP Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

SHP Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$744 Hold
17
– – ﹤0.01% 1540
2025
Q4 		$773 Buy
+17
New +$754 ﹤0.01% 1296

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

SHP Wealth Management's GNOM Position: Q1 2026 in Review

SHP Wealth Management held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q1 2026 at 17 shares worth $744. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

SHP Wealth Management first reported a position in GNOM in Q4 2025 and has held it in 2 quarters since. The position peaked at $773 in Q4 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • SHP Wealth Management held 17 shares of Global X Genomics & Biotechnology ETF worth $744 as of Q1 2026.
  • SHP Wealth Management left its Global X Genomics & Biotechnology ETF share count unchanged in Q1 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1540 holding.
  • SHP Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $773 in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.